Insider: SACHS BRUCE I Director - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 41,634 | 0 | 41,634 |
| Value | $15,898,775.58 | $0.00 | $15,898,775.58 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/06/2025 | AAP | 1,634 | Direct | COM | $389.36 | $636,214.24 | 41,634 |
| 08/06/2025 | AAP | 3,366 | Direct | COM | $389.84 | $1,312,201.44 | 45,000 |
| 08/01/2024 | DDS | 5,295 | Direct | COM | $508.00 | $2,689,860.00 | 40,000 |
| 05/22/2024 | DDS | 7,073 | Direct | COM | $448.00 | $3,168,704.00 | 40,000 |
| 11/06/2023 | DDS | 11,250 | Direct | COM | $385.00 | $4,331,250.00 | 40,000 |
| 07/17/2023 | DDS | 1,697 | Direct | COM | $355.54 | $603,351.38 | 49,553 |
| 07/17/2023 | DDS | 5,711 | Direct | COM | $356.75 | $2,037,399.25 | 43,842 |
| 07/17/2023 | DDS | 3,842 | Direct | COM | $357.29 | $1,372,708.18 | 40,000 |
| 04/12/2023 | DDS | 10,357 | Direct | COM | $326.46 | $3,381,146.22 | 49,236 |
| 04/12/2023 | DDS | 2,917 | Direct | COM | $325.65 | $949,921.05 | 59,593 |
| 04/12/2023 | DDS | 8,026 | Direct | COM | $327.48 | $2,628,354.48 | 41,210 |
| 01/31/2023 | DDS | 1,200 | Direct | COM | $325.01 | $390,012.00 | 41,210 |
| 08/02/2021 | AAP | 15,000 | Direct | COM | $197.91 | $2,968,650.00 | 41,210 |
| 11/10/2020 | AAP | 6,825 | Direct | COM | $216.47 | $1,477,407.75 | 18,035 |
| 11/10/2020 | AAP | 3,905 | Direct | COM | $218.79 | $854,374.95 | 26,210 |
| 11/10/2020 | AAP | 4,270 | Direct | COM | $217.49 | $928,682.30 | 22,305 |
| 05/07/2020 | DDS | 11,568 | Direct | COM | $268.65 | $3,107,743.20 | 42,042 |
| 05/07/2020 | DDS | 15,751 | Direct | COM | $269.53 | $4,245,367.03 | 26,291 |
| 05/07/2020 | DDS | 2,600 | Direct | COM | $267.50 | $695,500.00 | 53,610 |
| 05/07/2020 | DDS | 5,889 | Direct | COM | $270.49 | $1,592,915.61 | 20,402 |
| 05/07/2020 | DDS | 2,960 | Direct | COM | $272.46 | $806,481.60 | 11,210 |
| 05/07/2020 | DDS | 6,232 | Direct | COM | $271.63 | $1,692,798.16 | 14,170 |
| 01/31/2020 | DDS | 5,644 | Direct | COM | $227.01 | $1,281,244.44 | 17,810 |
| 01/31/2020 | DDS | 300 | Direct | COM | $227.66 | $68,298.00 | 17,510 |
| 01/31/2020 | DDS | 4,198 | Direct | COM | $226.32 | $950,091.36 | 23,454 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research